SCHEMBL396500

SCHEMBL396500

FCC(F)(C(F)(F)F)C(F)(F)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9587778 0.90 LMNA (0.33)
SCHEMBL3218836 0.81
SCHEMBL16610533 0.78
SCHEMBL28346370 0.76
SCHEMBL28433700 0.76
SCHEMBL17049723 0.72
SCHEMBL28428341 0.71
SCHEMBL2538298 0.70 THRB (0.31)
SCHEMBL2438517 0.70
SCHEMBL2688523 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-56050545-A None JP disclosed
JP-8307976-A None JP disclosed
US-12605469-B2 Tumor specific antibody conjugates and uses therefor THE UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE (US) 2026-04-21 US disclosed
US-20260007783-A1 A 3E8.scFv.Cys-IR800 Conjugate Targeting TAG-72 in an Orthotopic colorectal cancer model OHIO STATE INNOVATION FOUNDATION (US) 2026-01-08 US disclosed
US-12370273-B2 3E8.scFv.Cys-IR800 conjugate targeting TAG-72 in an orthotopic colorectal cancer model Ohio Sate Innovation Foundation (US) 2025-07-29 US disclosed
US-20240166762-A1 METHODS AND COMPOSITIONS RELATED TO ANTIBODY FRAGMENTS THAT BIND TO TUMOR-ASSOCIATED GLYCOPROTEIN 72 (TAG-72) OHIO STATE INNOVATION FOUNDATION (US) 2024-05-23 US disclosed
US-20240108764-A1 3E8.scFv.Cys-IR800 Conjugate Targeting TAG-72 in an Orthotopic colorectal cancer model OHIO STATE INNOVATION FOUNDATION 2024-04-04 US disclosed
US-11787872-B2 Methods and compositions related to antibody fragments that bind to tumor-associated glycoprotein 72 (TAG-72) OHIO STATE INNOVATION FOUNDATION (US) 2023-10-17 US disclosed
US-20230049618-A1 TUMOR SPECIFIC ANTIBODY CONJUGATES AND USES THEREFOR THE UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE (US) 2023-02-16 US disclosed
US-11554181-B2 Tumor specific antibody conjugates and uses therefor THE UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE (US) 2023-01-17 US disclosed
US-20030130190-A1 In vivo panning for ligands to radiation-induced molecules VANDERBILT UNIVERSITY 2003-07-10 US disclosed
US-20030127173-A1 Fixing belt and method for evaluating it RICOH COMPANY, LTD. (JP) 2003-07-10 US disclosed
EP-0988062-A4 SELECTIVELY BINDING ULTRASOUND CONTRAST AGENTS MALLINCKRODT INC (US) 2003-04-23 EP disclosed
WO-2003028640-A2 IN VIVO PANNING FOR LIGANDS TO RADIATION-INDUCED MOLECULES VANDERBILT UNIVERSITY (US) 2003-04-10 WO disclosed
US-6245318-B1 COMPOSITION COMPRISING ULTRASOUND CONTRAST, POLYMERIC SPACER AND LIGAND MALLINCKRODT INC. 2001-06-12 US disclosed
US-6059719-A Endoscope system OLYMPUS OPTICAL CO., LTD. (JP) 2000-05-09 US disclosed
EP-0988062-A1 SELECTIVELY BINDING ULTRASOUND CONTRAST AGENTS Mallinckrodt Inc. (US) 2000-03-29 EP disclosed
WO-1998053857-A1 SELECTIVELY BINDING ULTRASOUND CONTRAST AGENTS MALLINCKRODT MEDICAL, INC. (US) 1998-12-03 WO disclosed
JP-H08307976-A STAND FOR SPEAKER CABINET NIPPON COLUMBIA CO LTD 1996-11-22 JP disclosed
JP-S5650545-A RESIN MOLDED TYPE SEMICONDUCTOR DEVICE HITACHI LTD 1981-05-07 JP disclosed